Literature DB >> 20537700

Canine preantral follicles cultured with various concentrations of follicle-stimulating hormone (FSH).

Michelle Karen Brasil Serafim1, Valdevane Rocha Araújo, Gerlane Modesto Silva, Ana Beatriz Graça Duarte, Anderson Pinto Almeida, Roberta Nogueira Chaves, Cláudio Cabral Campello, Cláudio Afonso Pinho Lopes, José Ricardo de Figueiredo, Lúcia Daniel Machado da Silva.   

Abstract

The objective was to evaluate the effects of various concentrations of exogenous FSH during in vitro culture of isolated canine preantral follicles. Preantral secondary follicles (>200 microm) were isolated by microdissection and cultured for 18 d in supplemented alpha-Minimum Essential Medium (alpha-MEM). There were three treatment groups: 1) absence of FSH (control medium); 2) FSH100 (fixed concentration of 100 ng/mL throughout the entire culture period); and 3) sequential FSH (FSHSeq - 100, 500, and 1,000 ng/mL were added sequentially). Following culture, all follicles from all treatments were still viable (marked green by calcein-AM). The initial (D0) average follicle diameter for the control, FSH100, and FSHSeq was (mean +/- SEM) 298.96 +/- 7.02, 286.00 +/- 5.87, and 275.39 +/- 174 6.55 microm, respectively (P > 0.05). Mean diameter of follicles treated with FSHSeq on Day 18 (D18-439.80 +/- 14.08 microm) was greater than those of the other treatments (P < 0.05). Daily follicular growth rate (microm/d) of follicles in the FSHSeq treatment (6.47 +/- 0.55) was significantly faster than for both the control (3.67 +/- 0.32) and FSH100 (4.47 +/- 0.38) treatments. Furthermore, FSH100 and FSHSeq treatments had a significantly higher rate of antrum formation than the control group on D12 of culture, whereas after D12, FSH100 had a significantly higher rate of extrusion compared to the control (P < 0.05). In conclusion, the sequential addition of FSH to the culture medium maintained the survival of isolated canine preantral follicles and promoted an increased rate of follicular growth and antrum formation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537700     DOI: 10.1016/j.theriogenology.2010.03.028

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Cat and dog primordial follicles enclosed in ovarian cortex sustain viability after in vitro culture on agarose gel in a protein-free medium.

Authors:  M Fujihara; P Comizzoli; D E Wildt; N Songsasen
Journal:  Reprod Domest Anim       Date:  2012-12       Impact factor: 2.005

2.  Activin promotes growth and antral cavity expansion in the dog ovarian follicle.

Authors:  Jennifer B Nagashima; David E Wildt; Alexander J Travis; Nucharin Songsasen
Journal:  Theriogenology       Date:  2019-02-25       Impact factor: 2.740

3.  In vitro growth and steroidogenesis of dog follicles are influenced by the physical and hormonal microenvironment.

Authors:  N Songsasen; T K Woodruff; D E Wildt
Journal:  Reproduction       Date:  2011-04-18       Impact factor: 3.906

4.  In vitro development of secondary follicles from pre-pubertal and adult goats cultured in two-dimensional or three-dimensional systems.

Authors:  G M Silva; R Rossetto; R N Chaves; A B G Duarte; V R Araújo; C Feltrin; M P Bernuci; J A Anselmo-Franci; M Xu; T K Woodruff; C C Campello; J R Figueiredo
Journal:  Zygote       Date:  2014-03-26       Impact factor: 1.442

5.  Phytohemagglutinin improves the development and ultrastructure of in vitro-cultured goat (Capra hircus) preantral follicles.

Authors:  E V Cunha; J J N Costa; R O D S Rossi; A W B Silva; J R S Passos; A M L R Portela; D C S T Pereira; M A M Donato; C C Campello; M V A Saraiva; C A Peixoto; J R V Silva; R P Santos
Journal:  Braz J Med Biol Res       Date:  2013-03-19       Impact factor: 2.590

Review 6.  Canid Reproductive Biology: Norm and Unique Aspects in Strategies and Mechanisms.

Authors:  Jennifer B Nagashima; Nucharin Songsasen
Journal:  Animals (Basel)       Date:  2021-03-01       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.